| 상품명칭 |
Ormetoprim |
| 별명 |
Rofenaid; 2,4-Diamino-5-(4,5-dimethoxy-2-methylbenzyl)pyrimidin; 2,4-Diamino-5-(6-methylveratryl)pyrimidine; 2,4-Pyrimidinediamine, 5-((4,5-dimethoxy-2-methylphenyl)methyl)-; NSC 95072; Ormetoprima; Ormetoprima [INN-Spanish]; Ormetoprime; Ormetoprime [INN-French]; Ormetoprimum; Ormetoprimum [INN-Latin]; Ormetorprim; Ro 5-9754; UNII-M3EFS94984; component of Rofenaid; Pyrimidine, 2,4-diamino-5-(6-methylveratryl)-; 5-(4,5-dimethoxy-2-methylbenzyl)pyrimidine-2,4-diamine; 5-(2,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine; 5-(4,5-dimethoxy-2-methylbenzyl)-2,4-diaminopyrimidine |
| 분자식 |
C14H18N4O3 |
| 분자량 |
290.3177 |
| InChI |
InChI=1/C14H18N4O3/c1-19-10-6-12(21-3)11(20-2)5-8(10)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) |
| cas번호 |
6981-18-6 |
| EC번호 |
230-246-6 |
| 분자 구조 |
|
| 밀도 |
1.252g/cm3 |
| 비등점 |
535.302°C at 760 mmHg |
| 굴절 지수 |
1.609 |
| 인화점 |
277.541°C |
|
